Avalon GloboCare Corp. Common Stock (ALBT) Stock Price

ALBTStock
$1.69−87.50%52W
Market Cap$22.22M
P/E—
PEG Ratio—
Div yield—
Beta-0.19

ALBT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-97.72%
Price vs S&P 500 (4W)-25.33%
VGM Score32.76

Industry Peers — Computer Programming(50)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/S Ratio (TTM)Revenue Growth TTM (YoY)Gross Margin (TTM)Operating Margin (TTM)Price
ALBTAvalon GloboCare Corp. Common Stock
CDF2.9x6.7%25.7%-1217.5%$1.69
INFYInfosys Limited American Depositary SharesCCB2.4x11.2%30.2%20.4%$12.24
ZSZscaler, Inc. Common StockFAB9.8x25.4%76.8%-4.0%$207.38
CTSHCognizant Technology SolutionsBDA1.4x5.6%33.4%15.9%$66.03
VRSNVeriSign IncDDB16.0x6.9%88.5%67.9%$302.33
WITWipro LimitedBDB1.7x6.4%29.1%16.3%$1.95
EPAMEPAM SYSTEMS, INC.BCB1.1x10.8%29.4%10.0%$122.19
DOXAmdocs LimitedBDB1.4x0.1%38.3%13.5%$60.06
DOCSDoximity, Inc.DCB8.4x11.2%88.1%29.6%$30.97
RGTIRigetti Computing, Inc. Common StockFCD295.0x68.5%34.6%-727.6%$11.80
FORTYFormula Systems 1985 LtdBCB0.6x1.3%19.8%8.5%$114.59

About Avalon GloboCare Corp. Common Stock

Avalon Globocare Corp operates two primary segments: real property management, which is the primary revenue source, and laboratory testing services. The company develops diagnostic and therapeutic biotechnology solutions targeting early detection and treatment of cancers, including oral, ovarian, and kidney variants, as well as skin regeneration, anti-fibrosis, and degenerative disorder applications.